Pregnancy And Inflammatory Bowel Disease

Conception And The Effect IBD Medications Have On A Pregnancy And Baby

Pregnant African American mother holding her stomach
Women who have IBD can have a healthy pregnancy and baby. There are some things you should know in order to prepare for a pregnancy when you have IBD. Image © JGI/Tom Grill / Getty Images

Can Women With IBD Have Children?

Yes, women with inflammatory bowel disease (IBD) can have children. In the past, women with IBD were counseled against pregnancy. But current IBD management strategies have made having a baby safer for both mother and baby. Having a chronic illness while pregnant requires careful supervision by qualified physicians, but a healthy pregnancy and baby are both possible.

Do Men And Women With IBD Have Decreased Fertility Rates?

Fertility rates for women with IBD are the same as for women who are in good health. Women with active Crohn's disease may have a decrease in fertility. Family planning is an important topic for any woman, but especially for those with IBD. There are circumstances where pregnancy may not be advised, such as during a flare-up or while taking certain medications.

It has been known for many years that sulfasalazine (Azulfadine), a drug used to treat these conditions, can cause temporary infertility in about 60% of men. The sulfa component of the drug can alter sperm, but this effect is reversed within two months of stopping its use. Proctocolectomy surgery in men can cause impotence, though this is rare.

According to one review of the literature, infertility occurs in 48% of women who have surgery to treat ulcerative colitis. This is presumably due to scarring in the fallopian tubes that may occur after such extensive surgery.

The risk of infertility after colectomy has been in question for several years because many studies showed widely varying rates of infertility. There are similar reports of infertility in Crohn's disease patients.

What Effect Does Medication Have On Pregnancy?

As most women are now aware, it is better to avoid taking any drugs during pregnancy.

However, there are circumstances where the benefits of taking a drug may outweigh the risks.

Some medications for IBD are best avoided during pregnancy, but others are considered safe for the mother and fetus because of their long history of safe use by patients. The Food and Drug Administration (FDA) has a created a classification system for the use of medications during pregnancy (see Table 1 below).

Research studies have shown that some drugs commonly used for both maintenance therapy and acute flare-ups of IBD are safe for pregnant women to use. These are:

The immunosuppressive drugs azathioprine (Imuran [Pregnancy Category D]) and 6-mercaptopurine (Purinethol or 6-MP [Pregnancy Category D]) do cross the placenta and can be detected in cord blood. However, they might be recommended with caution during pregnancy by some physicians to combat a serious flare-up.

These drugs do not increase the risk of birth defects.

Methotrexate (Pregnancy Category X) and thalidomide (Pregnancy Category X) are two immunosuppressive drugs that should not be used during pregnancy as they do have an effect on an unborn child. Methotrexate can cause abortion and skeletal abnormalities, and it should be discontinued three months prior to conception, if possible. Thalidomide is well known for causing limb defects as well as other major organ complications in a fetus. Use is only permitted with rigorous birth control and frequent pregnancy testing.

Metronidazole (Flagyl [Pregnancy Category B]), an antibiotic that is occasionally used to treat complications associated with IBD, may not be safe for the fetus after the first trimester. One study showed that metronidazole did not cause birth defects in the first trimester, but no long-term studies have been conducted. Brief courses of this drug are often used during pregnancy, although longer courses are still controversial.

Infliximab (Remicade [Pregnancy Category C]) is a biologic drug for the treatment of IBD, and studies about its use during pregnancy are starting to become available. Women receiving infusions of infliximab should discuss treatment options with their physician in the event of a pregnancy. Most safety data is from animal studies, and extensive use in pregnant women has not been looked at.

How Does Pregnancy Affect The Course Of IBD?

The course of IBD throughout the term of a pregnancy tends to remain similar to one's condition at the time of conception. For this reason, it is important for women who are considering pregnancy to maintain their treatment regimen and work to bring, or to keep, their disease in remission.

Among women who conceive while their IBD is inactive, one-third improve, one-third worsen, and one-third experience no change in their disease. Among women who conceive while their ulcerative colitis is flaring, two-thirds will continue to experience active disease.

Physicians may treat a severe flare-up of IBD that occurs during an unplanned pregnancy very aggressively. Achieving remission is important to help ensure the pregnancy is as healthy as possible.

Table 1 - FDA Drug Categories

CategoryDescription
AAdequate, well-controlled studies in pregnant women have not shown increased risk of fetal abnormalities.
BAnimal studies reveal no evidence of harm to the fetus, however there are no adequate, well-controlled studies in pregnant women. OR Animal studies show an adverse effect, but adequate, well-controlled studies in pregnant women have failed to show a risk to the fetus.
CAnimal studies have shown adverse effect and there are no adequate, well-controlled studies in pregnant women. OR No animal studies have been conducted, there are no adequate, well-controlled studies in pregnant women.
DStudies, adequate, well-controlled or observational, in pregnant women have demonstrated risk to the fetus. However, benefits of therapy may outweigh potential risk.
XStudies, adequate well-controlled or observational, in animals or pregnant women have demonstrated positive evidence of fetal abnormalities. Product is contraindicated in women who are or may become pregnant.

Are There Any Complications With Pregnancy And IBD?

For women with ulcerative colitis and Crohn's disease in remission, the risks of miscarriage, stillbirth and congenital abnormality are the same as those for healthy women. A flare-up of Crohn's disease at the time of conception or during the course of a pregnancy is associated with a higher risk of miscarriage and premature birth.

Hemorrhoids are a common problem for pregnant women, with up to 50 percent of women suffering through them.

Symptoms of IBD, such as diarrhea or constipation, can actually increase the risk of hemorrhoids. There are several treatments that will shrink hemorrhoids such as Kegel exercises, keeping the anal area clean, avoiding sitting and standing for long periods of time and heavy or moderate lifting, using petroleum jelly to cool off the rectum and ease bowel movements, sitting on an ice pack for relief from burning, sitting in enough warm water to cover the hemorrhoids, and using suppositories or creams.

Does IBD Get Passed On To Children?

Some people with IBD may remain childless because of a concern that children could inherit their disease. In recent years, there has been a focus on the idea that IBD runs in families and may even be linked to particular genes. Researchers have no clear answers about how IBD is passed between generations, but there is some research on the probability of children inheriting their parent's disease.

There seems to be a stronger risk of inheriting Crohn's disease than ulcerative colitis, especially in Jewish families. However, children who have one parent with Crohn's disease have only a 7 to 9% lifetime risk of developing the condition, and just a 10% risk of developing some form of IBD. If both parents have IBD, this risk is increased to about 35%.

What Will Help Before Conception or During Pregnancy?

Women are now encouraged to get their bodies prepared for a pregnancy by increasing intake of folic acid, quitting smoking, getting more exercise, and eating healthier. For women with IBD, the greatest factor influencing the course of the pregnancy and the health of the baby is the state of disease activity. Discontinuing any medications that may be harmful to the developing fetus is also important. A pregnancy planned when the IBD is in remission has the greatest chance for a favorable outcome.

Sources:

Eisenberg S, Friedman LS. "Inflammatory bowel disease in pregnancy." Practical Gastroenterol .1990.

E M Alstead. "Inflammatory bowel disease in pregnancy." Postgraduate Medical Journal. 2002.

Akbar Waljee, Jennifer Waljee, Arden Morris, Peter D.R. Higgins. "Three-fold increased risk of infertility: a meta-analysis of infertility after pouch surgery in ulcerative colitis." Gut.13 June 2006.

Norgard B, Czeizel AE, Rockenbauer M, et al. "Population-based case control study of the safety of sulfasalazine use during pregnancy." Aliment Pharmacol Ther. 2001.

Habal FM, Hui G, Greenberg GR. "Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course." Gastroenterology. 1993.

Janssen NM, Genta MS. "The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation." Arch Intern Med. 2000.

Burtin P, Taddio A, Ariburnu O, et al. "Safety of metronidazole in pregnancy: a meta-analysis." Am J Obstet Gynecol. 1995.

Dayan A, Rubin P, Chapman M, Present D. "6-Mercaptopurine (6MP) use in inflammatory bowel disease (IBD) in patients of childbearing age: an increase in congenital anomalies--a case-controlled study." Gastroenterology. 1991.

Alstead EM, Ritchie JK, Lennard-Jones JE, et al. "Safety of azathioprine in pregnancy in inflammatory bowel disease." Gastroenterology. 1990.

Nguyen C, Duhl AJ, Escallon CS, Blakemore KJ. "Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester." Obstet Gynecol. 2002. 

Bousvaros A, Mueller B. "Thalidomide in gastrointestinal disorders." Drugs. 2001.

Diav-Citrin O, Shechtman S, Gotteiner T, et al. "Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study." Teratology. May 2001. 

Caro-Patón T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodríguez Pinilla E. "Is metronidazole teratogenic? A meta-analysis." Br J Clin Pharmacol. Aug 1997.

A. Katz, Christian Antoni, Gregory F. Keenan, Deirdre E. Smith, Stephen J. Jacobs, Gary R. Lichtenstein. "Outcome of Pregnancy in Women Receiving Infliximab for the Treatment of Crohn's Disease and Rheumatoid Arthritis." The American Journal of Gastroenterology. Dec 2004. 

U. Mahadevan, S. Kane, W. J. Sandborn, R. D. Cohen, K. Hanson, J. P. Terdiman, D. G. Binion. "Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease." Alimentary Pharmacology & Therapeutics. Mar 2005. 

Khosla R, Willoughby CP, Jewell DP. "Crohn's disease and pregnancy." Gut. 1984.

Willoughby CP, Truelove SC. "Ulcerative colitis and pregnancy." Gut. 1980.

Hanan IM, Kirsner JB. "Inflammatory bowel disease in the pregnant woman." Clin Perinatol. 1985. 

Nielsen OH, Andreasson B, Bondesen S, Jarnum S. "Pregnancy in ulcerative colitis." Scand J Gastroenterol. 1983. 

Porter RJ, Stirrat GM. "The effects of inflammatory bowel disease on pregnancy: A case-controlled retrospective analysis." Br J Obstet Gynaecol. 1986.

Baiocco PJ, Korelitz BL. "The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome." J Clin Gastroenterology. 1984. 

Miller JP. "Inflammatory bowel disease in pregnancy: a review." J Royal Soc Med. 1986.

Bente Nørgård, M.D., Ph.D., Heidi H. Hundborg, M.Sc., Ph.D , Bent A. Jacobsen, M.D. , Gunnar L Nielsen, M.D., Kirsten Fonager, M.D., Ph.D. "Disease Activity in Pregnant Women With Crohn's Disease and Birth Outcomes: A Regional Danish Cohort Study." Am J Gastroenterol. Jul 2007.

Peeters M, Nevens H, Baert F, et al. "Familial aggregation in Crohn's disease: Increased age, adjusted risk and concordance in clinical characteristics." Gastroenterology. 1996. 

Continue Reading